Last reviewed · How we verify
Letrozole or anastrozole or Fulvestrant — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Letrozole or anastrozole or Fulvestrant (Letrozole or anastrozole or Fulvestrant) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Letrozole or anastrozole or Fulvestrant TARGET | Letrozole or anastrozole or Fulvestrant | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Letrozole or anastrozole or Fulvestrant CI watch — RSS
- Letrozole or anastrozole or Fulvestrant CI watch — Atom
- Letrozole or anastrozole or Fulvestrant CI watch — JSON
- Letrozole or anastrozole or Fulvestrant alone — RSS
Cite this brief
Drug Landscape (2026). Letrozole or anastrozole or Fulvestrant — Competitive Intelligence Brief. https://druglandscape.com/ci/letrozole-or-anastrozole-or-fulvestrant. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab